Selected news related to activities of van Rooijen & Partners.

Management challenges in biotech. (European Biopharmaceutical Review) More >>

In- and Outlicensing. (European Pharmaceutical Contractor) More >>

Indian Biotech – A Fledgling Industry Takes Flight. (European Biopharmaceutical Review) More >>

Affectis Pharmaceuticals AG Announces Target Validation Collaboration with Organon. More >>

Undisclosed client licenses a therapeutic product in clinical development to US biotech.

Indian contract manufacturer acquires European client.

Inamed acquires patent for inhalation of aspirin to treat virus infection More >>

Boehringer Ingelheim and NascaCell announce research collaboration on aptamers. More >>

Pharmexa acquires patent estate from Vectron Therapeutics AG. More >>

Morphochem/Migragen collaboration sells Rho-kinase patent to Schering AG. More >>

NascaCell announces a collaboration agreement with Aventis. More >>

Merz Pharmaceuticals and NascaCell announce collaboration agreement to use aptamers in the validation of several targets. More >>

Election as a partner of the High-Tech Gründerfonds.

Lucio van Rooijen elected to the supervisory board of humatrix AG, a DNA diagnostics company.

100.000 euros for growth companies: the STEP Award 2008. More >>

100.000 euros for growth companies: the STEP Award 2007. More >>

100.000 euros for growth companies: the STEP Award 2006. More >>


If you wish to be added to the mailing list. >>